nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—Crohn's disease	0.605	1	CbGaD
Pranlukast—ABCC2—Sulfasalazine—Crohn's disease	0.0509	0.865	CbGbCtD
Pranlukast—MUC2—gall bladder—Crohn's disease	0.0116	0.117	CbGeAlD
Pranlukast—ABCC2—bile—Crohn's disease	0.00933	0.0945	CbGeAlD
Pranlukast—CYP3A4—Prednisone—Crohn's disease	0.00796	0.135	CbGbCtD
Pranlukast—IL5—epithelium—Crohn's disease	0.00779	0.0788	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—Crohn's disease	0.0066	0.0669	CbGeAlD
Pranlukast—RNASE3—digestive system—Crohn's disease	0.00652	0.066	CbGeAlD
Pranlukast—IL5—lymphoid tissue—Crohn's disease	0.006	0.0607	CbGeAlD
Pranlukast—MUC2—epithelium—Crohn's disease	0.00599	0.0606	CbGeAlD
Pranlukast—IL5—digestive system—Crohn's disease	0.00592	0.06	CbGeAlD
Pranlukast—NFKB1—mouth—Crohn's disease	0.00587	0.0594	CbGeAlD
Pranlukast—MUC2—digestive system—Crohn's disease	0.00456	0.0461	CbGeAlD
Pranlukast—IL5—lymph node—Crohn's disease	0.00338	0.0343	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—Crohn's disease	0.00323	0.0327	CbGeAlD
Pranlukast—NFKB1—mammalian vulva—Crohn's disease	0.00296	0.03	CbGeAlD
Pranlukast—CYSLTR1—mammalian vulva—Crohn's disease	0.00291	0.0294	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—Crohn's disease	0.00263	0.0266	CbGeAlD
Pranlukast—TNF—lymph node—Crohn's disease	0.0026	0.0263	CbGeAlD
Pranlukast—NFKB1—digestive system—Crohn's disease	0.0026	0.0263	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—Crohn's disease	0.00258	0.0261	CbGeAlD
Pranlukast—NFKB1—lymph node—Crohn's disease	0.00148	0.015	CbGeAlD
Pranlukast—CYSLTR1—lymph node—Crohn's disease	0.00146	0.0148	CbGeAlD
Pranlukast—ABCC2—digestive system—Crohn's disease	0.00102	0.0103	CbGeAlD
Pranlukast—CYP2C9—digestive system—Crohn's disease	0.000679	0.00688	CbGeAlD
Pranlukast—ABCC2—lymph node—Crohn's disease	0.000582	0.0059	CbGeAlD
Pranlukast—CYP3A4—digestive system—Crohn's disease	0.000518	0.00524	CbGeAlD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—Crohn's disease	7.76e-05	0.000327	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	7.69e-05	0.000324	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—JAK2—Crohn's disease	7.68e-05	0.000324	CbGpPWpGaD
Pranlukast—TNF—Vitamin B12 Metabolism—IL6—Crohn's disease	7.65e-05	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—TYK2—Crohn's disease	7.58e-05	0.00032	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	7.5e-05	0.000316	CbGpPWpGaD
Pranlukast—IL5—Immune System—SOCS1—Crohn's disease	7.5e-05	0.000316	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IFNG—Crohn's disease	7.48e-05	0.000315	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2RA—Crohn's disease	7.46e-05	0.000314	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GPR65—Crohn's disease	7.43e-05	0.000313	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL3—Crohn's disease	7.4e-05	0.000312	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.39e-05	0.000311	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCR6—Crohn's disease	7.38e-05	0.000311	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Crohn's disease	7.37e-05	0.000311	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—Crohn's disease	7.34e-05	0.000309	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	7.31e-05	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—JAK2—Crohn's disease	7.23e-05	0.000305	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2RA—Crohn's disease	7.22e-05	0.000304	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—Crohn's disease	7.17e-05	0.000302	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—RASGRP1—Crohn's disease	7.16e-05	0.000302	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	7.14e-05	0.000301	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	7.04e-05	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	7.01e-05	0.000295	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CARD9—Crohn's disease	7e-05	0.000295	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CXCL8—Crohn's disease	6.96e-05	0.000293	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RBX1—Crohn's disease	6.91e-05	0.000291	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ACKR2—Crohn's disease	6.89e-05	0.00029	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	6.86e-05	0.000289	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL18—Crohn's disease	6.75e-05	0.000284	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL3—Crohn's disease	6.72e-05	0.000283	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1B—Crohn's disease	6.68e-05	0.000281	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RBX1—Crohn's disease	6.67e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 cascade initiated on plasma membrane—IL6—Crohn's disease	6.67e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	6.61e-05	0.000278	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—Crohn's disease	6.6e-05	0.000278	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2RA—Crohn's disease	6.56e-05	0.000276	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MLN—Crohn's disease	6.53e-05	0.000275	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RASGRP1—Crohn's disease	6.5e-05	0.000274	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTGER4—Crohn's disease	6.5e-05	0.000274	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.49e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—Crohn's disease	6.49e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	6.49e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—ICAM1—Crohn's disease	6.47e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	6.41e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—Crohn's disease	6.37e-05	0.000268	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CXCL8—Crohn's disease	6.35e-05	0.000267	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—Crohn's disease	6.32e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—UBE2D1—Crohn's disease	6.31e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—STAT3—Crohn's disease	6.26e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—Crohn's disease	6.26e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	6.26e-05	0.000264	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—Crohn's disease	6.22e-05	0.000262	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	6.15e-05	0.000259	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RIPK2—Crohn's disease	6.12e-05	0.000258	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	6.1e-05	0.000257	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—UBE2D1—Crohn's disease	6.06e-05	0.000255	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2RA—Crohn's disease	5.99e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAGAP—Crohn's disease	5.97e-05	0.000252	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—Crohn's disease	5.9e-05	0.000249	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RIPK2—Crohn's disease	5.88e-05	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ITGA4—Crohn's disease	5.88e-05	0.000248	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	5.86e-05	0.000247	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—UBE2D1—Crohn's disease	5.85e-05	0.000247	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.84e-05	0.000246	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RASGRP1—Crohn's disease	5.77e-05	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	5.76e-05	0.000243	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.74e-05	0.000242	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RIPK2—Crohn's disease	5.67e-05	0.000239	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—Crohn's disease	5.65e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TAB1—Crohn's disease	5.65e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—Crohn's disease	5.63e-05	0.000237	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—Crohn's disease	5.63e-05	0.000237	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.61e-05	0.000236	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	5.58e-05	0.000235	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	5.57e-05	0.000235	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NOD2—Crohn's disease	5.55e-05	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RASGRP1—Crohn's disease	5.55e-05	0.000234	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL3—Crohn's disease	5.53e-05	0.000233	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD79A—Crohn's disease	5.53e-05	0.000233	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—Crohn's disease	5.51e-05	0.000232	CbGpPWpGaD
Pranlukast—IL5—Immune System—TLR4—Crohn's disease	5.42e-05	0.000228	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RASGRP1—Crohn's disease	5.35e-05	0.000225	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—Crohn's disease	5.34e-05	0.000225	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—Crohn's disease	5.31e-05	0.000224	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR6—Crohn's disease	5.3e-05	0.000223	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.26e-05	0.000222	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—TYK2—Crohn's disease	5.25e-05	0.000221	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—SOCS1—Crohn's disease	5.23e-05	0.00022	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RSPO3—Crohn's disease	5.22e-05	0.00022	CbGpPWpGaD
Pranlukast—IL5—Immune System—ICAM1—Crohn's disease	5.2e-05	0.000219	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2RA—Crohn's disease	5.19e-05	0.000218	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—STAT3—Crohn's disease	5.18e-05	0.000218	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—TYK2—Crohn's disease	5.17e-05	0.000218	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—SMAD3—Crohn's disease	5.11e-05	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NOD1—Crohn's disease	5.11e-05	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—STAT3—Crohn's disease	5.1e-05	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—Crohn's disease	5.09e-05	0.000214	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—Crohn's disease	5.03e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—SOCS1—Crohn's disease	5.02e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—JAK2—Crohn's disease	5.01e-05	0.000211	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	5e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SEL1L—Crohn's disease	4.95e-05	0.000209	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—Crohn's disease	4.94e-05	0.000208	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—JAK2—Crohn's disease	4.93e-05	0.000208	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IFNG—Crohn's disease	4.92e-05	0.000207	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.88e-05	0.000206	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—JAK2—Crohn's disease	4.86e-05	0.000205	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SOCS1—Crohn's disease	4.85e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—Crohn's disease	4.8e-05	0.000202	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—Crohn's disease	4.79e-05	0.000202	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RBX1—Crohn's disease	4.79e-05	0.000202	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—Crohn's disease	4.77e-05	0.000201	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2RA—Crohn's disease	4.71e-05	0.000198	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTGER4—Crohn's disease	4.66e-05	0.000196	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CCR6—Crohn's disease	4.64e-05	0.000195	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—TYK2—Crohn's disease	4.62e-05	0.000195	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR9—Crohn's disease	4.53e-05	0.000191	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	4.5e-05	0.00019	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—Crohn's disease	4.45e-05	0.000187	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—Crohn's disease	4.43e-05	0.000187	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—JAK2—Crohn's disease	4.41e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	4.39e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—Crohn's disease	4.39e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.32e-05	0.000182	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.26e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTPN2—Crohn's disease	4.24e-05	0.000179	CbGpPWpGaD
Pranlukast—IL5—Immune System—TYK2—Crohn's disease	4.22e-05	0.000178	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GPR65—Crohn's disease	4.21e-05	0.000177	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—UBE2D1—Crohn's disease	4.2e-05	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RBX1—Crohn's disease	4.19e-05	0.000177	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMAD3—Crohn's disease	4.19e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	4.12e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.1e-05	0.000173	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RIPK2—Crohn's disease	4.07e-05	0.000172	CbGpPWpGaD
Pranlukast—IL5—Immune System—JAK2—Crohn's disease	4.03e-05	0.00017	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—Crohn's disease	4.02e-05	0.00017	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL3—Crohn's disease	3.97e-05	0.000167	CbGpPWpGaD
Pranlukast—IL5—Immune System—IFNG—Crohn's disease	3.95e-05	0.000167	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—Crohn's disease	3.95e-05	0.000166	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—Crohn's disease	3.91e-05	0.000165	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SMAD3—Crohn's disease	3.9e-05	0.000164	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2RA—Crohn's disease	3.88e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—STAT3—Crohn's disease	3.86e-05	0.000162	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RASGRP1—Crohn's disease	3.84e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—Crohn's disease	3.82e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—Crohn's disease	3.78e-05	0.000159	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	3.71e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—STAT3—Crohn's disease	3.68e-05	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—UBE2D1—Crohn's disease	3.68e-05	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—STAT3—Crohn's disease	3.62e-05	0.000152	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—Crohn's disease	3.62e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RIPK2—Crohn's disease	3.57e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGA4—Crohn's disease	3.57e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—Crohn's disease	3.56e-05	0.00015	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—Crohn's disease	3.53e-05	0.000149	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—JAK2—Crohn's disease	3.49e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ICAM1—Crohn's disease	3.48e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SOCS1—Crohn's disease	3.48e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL3—Crohn's disease	3.48e-05	0.000147	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	3.43e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RASGRP1—Crohn's disease	3.36e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD79A—Crohn's disease	3.35e-05	0.000141	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TYK2—Crohn's disease	3.34e-05	0.000141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TYK2—Crohn's disease	3.32e-05	0.00014	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.31e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TAB1—Crohn's disease	3.29e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NOD2—Crohn's disease	3.23e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—JAK2—Crohn's disease	3.18e-05	0.000134	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—Crohn's disease	3.18e-05	0.000134	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—JAK2—Crohn's disease	3.16e-05	0.000133	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.13e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.1e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SOCS1—Crohn's disease	3.05e-05	0.000128	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMAD3—Crohn's disease	3e-05	0.000127	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR6—Crohn's disease	3e-05	0.000126	CbGpPWpGaD
Pranlukast—IL5—Immune System—STAT3—Crohn's disease	2.96e-05	0.000125	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TYK2—Crohn's disease	2.95e-05	0.000124	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—Crohn's disease	2.89e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—JAK2—Crohn's disease	2.81e-05	0.000118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2RA—Crohn's disease	2.78e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL18—Crohn's disease	2.74e-05	0.000116	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TYK2—Crohn's disease	2.73e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RBX1—Crohn's disease	2.71e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—Crohn's disease	2.69e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—Crohn's disease	2.66e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTGER4—Crohn's disease	2.64e-05	0.000111	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—JAK2—Crohn's disease	2.61e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—Crohn's disease	2.57e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—Crohn's disease	2.56e-05	0.000108	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TYK2—Crohn's disease	2.54e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—Crohn's disease	2.53e-05	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2RA—Crohn's disease	2.44e-05	0.000103	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—JAK2—Crohn's disease	2.43e-05	0.000102	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—Crohn's disease	2.38e-05	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—UBE2D1—Crohn's disease	2.38e-05	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—STAT3—Crohn's disease	2.34e-05	9.84e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RIPK2—Crohn's disease	2.31e-05	9.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—Crohn's disease	2.3e-05	9.68e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—Crohn's disease	2.26e-05	9.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL3—Crohn's disease	2.25e-05	9.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.23e-05	9.39e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—Crohn's disease	2.2e-05	9.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RASGRP1—Crohn's disease	2.17e-05	9.16e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ICAM1—Crohn's disease	2.11e-05	8.9e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—Crohn's disease	2.07e-05	8.7e-05	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.07e-05	8.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—Crohn's disease	2.02e-05	8.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SOCS1—Crohn's disease	1.97e-05	8.3e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TYK2—Crohn's disease	1.96e-05	8.26e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—STAT3—Crohn's disease	1.91e-05	8.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.89e-05	7.98e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—JAK2—Crohn's disease	1.87e-05	7.88e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—STAT3—Crohn's disease	1.78e-05	7.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TYK2—Crohn's disease	1.72e-05	7.23e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—Crohn's disease	1.71e-05	7.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMAD3—Crohn's disease	1.7e-05	7.17e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—JAK2—Crohn's disease	1.64e-05	6.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—Crohn's disease	1.63e-05	6.88e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—Crohn's disease	1.62e-05	6.84e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—Crohn's disease	1.61e-05	6.77e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2RA—Crohn's disease	1.57e-05	6.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—Crohn's disease	1.55e-05	6.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FADS1—Crohn's disease	1.48e-05	6.22e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.47e-05	6.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—Crohn's disease	1.44e-05	6.07e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—Crohn's disease	1.43e-05	6.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX4—Crohn's disease	1.38e-05	5.82e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT3—Crohn's disease	1.37e-05	5.78e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—Crohn's disease	1.34e-05	5.63e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCKR—Crohn's disease	1.34e-05	5.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.25e-05	5.27e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—Crohn's disease	1.24e-05	5.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT3—Crohn's disease	1.2e-05	5.06e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TYK2—Crohn's disease	1.11e-05	4.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JAK2—Crohn's disease	1.06e-05	4.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FADS1—Crohn's disease	9.74e-06	4.1e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—Crohn's disease	9.66e-06	4.07e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—Crohn's disease	9.59e-06	4.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.54e-06	4.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX4—Crohn's disease	9.12e-06	3.84e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCKR—Crohn's disease	8.81e-06	3.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—Crohn's disease	8.39e-06	3.54e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.35e-06	3.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT3—Crohn's disease	7.77e-06	3.27e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—Crohn's disease	5.43e-06	2.29e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—Crohn's disease	4.25e-06	1.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—Crohn's disease	3.72e-06	1.57e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—Crohn's disease	2.8e-06	1.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.45e-06	1.03e-05	CbGpPWpGaD
